SUMMA RX LABORATORIES INC
10QSB, EX-27, 2000-09-26
PHARMACEUTICAL PREPARATIONS
Previous: SUMMA RX LABORATORIES INC, 10QSB, 2000-09-26
Next: SUMMA RX LABORATORIES INC, 10QSB, 2000-09-26



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-QSB
FOR THE QUARTER ENDED OCTOBER 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-QSB FOR THE QUARTER ENDED OCTOBER 31, 1999.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-START>                             MAY-01-1999
<PERIOD-END>                               OCT-31-1999
<CASH>                                         110,513
<SECURITIES>                                         0
<RECEIVABLES>                                  474,186
<ALLOWANCES>                                   176,322
<INVENTORY>                                    307,242
<CURRENT-ASSETS>                               798,014
<PP&E>                                       1,678,991
<DEPRECIATION>                                 635,358
<TOTAL-ASSETS>                               1,843,325
<CURRENT-LIABILITIES>                          989,097
<BONDS>                                        570,000
                                0
                                          0
<COMMON>                                        31,458
<OTHER-SE>                                     252,770
<TOTAL-LIABILITY-AND-EQUITY>                 1,843,325
<SALES>                                      1,513,148
<TOTAL-REVENUES>                             1,513,148
<CGS>                                        1,191,259
<TOTAL-COSTS>                                1,741,090
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              37,417
<INCOME-PRETAX>                              (265,359)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (265,359)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (265,359)
<EPS-BASIC>                                     (0.08)
<EPS-DILUTED>                                   (0.08)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission